Top

Journal of Neurology

Published in:

Open Access 01-07-2020 | SARS-CoV-2 | Letter to the Editors

CNS penetration of potential anti-COVID-19 drugs

Authors: Peter J. Richardson, Silvia Ottaviani, Alessandro Prelle, Justin Stebbing, Giacomo Casalini, Mario Corbellino

Published in: Journal of Neurology | Issue 7/2020

Excerpt

Dear Sirs, …

Gu J, Gong E, Zhang B, Zheng J, Gao Z, Zhong Y, Zou W et al (2005) Multiple organ infection and the pathogenesis of SARS. J Exp Med 202(3):415–424. https://doi.org/10.1084/jem.20050828 CrossRefPubMedPubMedCentral

Baig AM, Khaleeq A, Ali U, Syeda H (2020) Evidence of the COVID-19 virus targeting the CNS: tissue distribution, host-virus interaction, and proposed neurotropic mechanisms. ACS Chem Neurosci 11(7):995–998. https://doi.org/10.1021/acschemneuro.0c00122 CrossRefPubMed

Ye M, Ren Y, Lv T (2020) Encephalitis as a clinical manifestation of COVID-19. Brain Behav Immun. https://doi.org/10.1016/j.bbi.2020.04.017 CrossRefPubMedPubMedCentral

Moriguchi T, Harii N, Goto J, Harada D, Sugawara H, Takamino J, Ueno M et al (2020) A first case of meningitis/encephalitis associated with SARS-Coronavirus-2. Int J Infect Dis 94:55–58. https://doi.org/10.1016/j.ijid.2020.03.062 CrossRefPubMedPubMedCentral

Wu Y, Xu X, Chen Z, Duan J, Hashimoto K, Yang L, Liu C et al (2020) Nervous system involvement after infection with COVID-19 and other coronaviruses. Brain Behav Immun. https://doi.org/10.1016/j.bbi.2020.03.031 CrossRefPubMedPubMedCentral

Xiang P, Xu XM, Gao LL, Wang HZ, Xiong HF, Li RH (2020) First case of 2019 novel coronavirus disease with Encephalitis. ChinaXiv T 202003:00015

Mao L, Wang M, Chen S, He Q, Chang J, Hong C, Zhou Y et al (2020) Neurological manifestations of hospitalized patients with COVID-19 in Wuhan, China: a retrospective case series study. MedRxiv. https://doi.org/10.1101/2020.02.22.20026500 CrossRefPubMedPubMedCentral

Helms J, Kremer S, Merdji H, Clere-Jehl R, Schenck M, Kummerlen C, Collange O et al (2020) Neurologic features in severe SARS-CoV-2 infection. N Engl J Med. https://doi.org/10.1056/NEJMc2008597 CrossRefPubMedPubMedCentral

Richardson P, Griffin I, Tucker C, Smith D, Oechsle O, Phelan A, Stebbing J (2020) Baricitinib as potential treatment for 2019-nCoV acute respiratory disease. Lancet 395(10223):e30–e31. https://doi.org/10.1016/S0140-6736(20)30304-4 CrossRefPubMedPubMedCentral

10.

Stebbing J, Phelan A, Griffin I, Tucker C, Oechsle O, Smith D, Richardson P (2020) COVID-19: combining antiviral and anti-inflammatory treatments. Lancet Infect Dis 20(4):400–402. https://doi.org/10.1016/S1473-3099(20)30132-8 CrossRefPubMedPubMedCentral

11.

Stebbing J, Krishnan V, de Bono S, Ottaviani S, Casalini G, Richardson PJ, Monteil V et al (2020) Mechanism of baricitinib supports artificial intelligence-predicted testing in COVID-19 patients. Res Square. https://doi.org/10.21203/rs.3.rs-23195/v1 CrossRef

12.

Gavegnano C, Haile WB, Hurwitz S, Tao S, Jiang Y, Schinazi RF, Tyor WR (2019) Baricitinib reverses HIV-associated neurocognitive disorders in a SCID mouse model and reservoir seeding in vitro. J Neuroinflamm 16(1):182. https://doi.org/10.1186/s12974-019-1565-6 CrossRef

13.

Jackson KM, Hansen RJ, Gustafson DL (2016) Pharmacokinetic and pharmacodynamic assessment of autophagy inhibition following hydroxychloroquine in mice. Cancer Res. https://doi.org/10.1158/1538-7445.AM2016-2084 CrossRefPubMed

14.

Zhang Q, Zhang Y, Diamond S, Boer J, Harris JJ, Li Y, Rupar M et al (2014) The Janus kinase 2 inhibitor fedratinib inhibits thiamine uptake: a putative mechanism for the onset of Wernicke’s encephalopathy. Drug Metab Dispos 42(10):1656–1662. https://doi.org/10.1124/dmd.114.058883 CrossRefPubMed

15.

Warren TK, Jordan R, Lo MK, Ray AS, Mackman RL, Soloveva V, Siegel D et al (2016) Therapeutic efficacy of the small molecule GS-5734 against Ebola virus in rhesus monkeys. Nature 531(7594):381–385. https://doi.org/10.1038/nature17180 CrossRefPubMedPubMedCentral

16.

Nellan A, McCully CML, Cruz Garcia R, Jayaprakash N, Widemann BC, Lee DW, Warren KE (2018) Improved CNS exposure to tocilizumab after cerebrospinal fluid compared to intravenous administration in rhesus macaques. Blood 132(6):662–666. https://doi.org/10.1182/blood-2018-05-846428 CrossRefPubMedPubMedCentral

17.

Ene L, Duiculescu D, Ruta SM (2011) How much do antiretroviral drugs penetrate into the central nervous system? J Med Life 4(4):432–439PubMedPubMedCentral

18.

Bixler SL, Bocan TM, Wells J, Wetzel KS, Van Tongeren SA, Garza NL, Donnelly G et al (2018) Intracellular conversion and in vivo dose response of favipiravir (T-705) in rodents infected with Ebola virus. Antiviral Res 151:50–54. https://doi.org/10.1016/j.antiviral.2017.12.020 CrossRefPubMed

19.

Jaruratanasirikul S, Hortiwakul R, Tantisarasart T, Phuenpathom N, Tussanasunthornwong S (1996) Distribution of azithromycin into brain tissue, cerebrospinal fluid, and aqueous humor of the eye. Antimicrob Agents Chemother 40(3):825–826. https://doi.org/10.1128/aac.40.3.825 CrossRefPubMedPubMedCentral

Title: CNS penetration of potential anti-COVID-19 drugs
Authors: Peter J. Richardson
Silvia Ottaviani
Alessandro Prelle
Justin Stebbing
Giacomo Casalini
Mario Corbellino
Publication date: 01-07-2020
Publisher: Springer Berlin Heidelberg
Keywords: SARS-CoV-2
COVID-19
Ruxolitinib
Published in: Journal of Neurology / Issue 7/2020
Print ISSN: 0340-5354
Electronic ISSN: 1432-1459
DOI: https://doi.org/10.1007/s00415-020-09866-5

At a glance: The STEP trials

Springer Medicine

CNS penetration of potential anti-COVID-19 drugs

Excerpt

At a glance: The STEP trials

Springer Medicine

Excerpt

Please log in to get access to this content

Other articles of this Issue 7/2020

Ischemic stroke and dose adjustment of oral Factor Xa inhibitors in patients with atrial fibrillation

Physical activity as a risk factor for amyotrophic lateral sclerosis-findings from three large European cohorts

Guillain-Barré syndrome following COVID-19: new infection, old complication?

Spatial metabolic profiles to discriminate dementia with Lewy bodies from Alzheimer disease

Early immunotherapy is highly effective in IgG1/IgG4 positive IgLON5 disease

Tele-health in neurology: an indispensable tool in the management of the SARS-CoV-2 epidemic